Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate the non-inferiority of CHF 5993 pMDI versus fixed combination of fluticasone furoate/vilanterol plus tiotropium in terms of quality of life (change from baseline in the St. George’s Respiratory Questionnaire [SGRQ] total score after 26 weeks of treatment).
Inclusion criteria
- Chronic Obstructive Pulmonary Disease